Document is current
Any future updates will be listed below
-
Authors
Thon, Jan Niklas
Schenz, Judith
Merle, Uta
Dietrich, Maximilian
Theobald, Vivienne
Weigand, Markus Alexander
Siegler, Benedikt Hermann
-
Funding
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 28 January 2025
Accepted: 21 May 2025
First Online: 27 May 2025
Declarations
:
: Markus A. Weigand holds patent EP/25.10.17/EPA17198330 Delta like ligand for diagnosing severe infections and is co-founder of the Delta Theragnostics GmbH. All other authors declare no conflict of interest.
